Simultaneous pre-filtration of multiple samples of water-soluble or organic solvent samples!
Cytiva's filter plates can perform pre-filtration of the majority of samples simultaneously using centrifugation or suction manifolds. For precise filtration of common aqueous solutions, we recommend the use of Supor (PES) membranes. Supor has high flow characteristics and is an excellent membrane material that meets the requirements for biological, pharmaceutical research, and sterilizing filtration. It also has low protein binding and broad chemical compatibility. Supor membranes are available in various pore sizes depending on the purpose of sample pre-treatment. ■ 0.1 μm - Reduction of mycoplasma ■ 0.2 μm - Sterilizing filtration ■ 0.45 μm - Clarification, filtration of large viruses ■ 0.8 - 5 μm - Removal of large particles, pre-filtration For the clarification of cells or lysates, filter plates equipped with pre-filters are recommended. By incorporating a pre-filter, clogging of the main filter is less likely to occur.
Inquire About This Product
basic information
This is a filter plate for the pretreatment of analytical test samples and biological samples. Target products: ■ 24-well filter plate, 7 mL Supor EKV membrane (0.2 µm, with depth media) Supor membrane (0.1, 0.45, 0.8, 1.2, 5 µm) ■ 96-well filter plate, 350 µL Supor membrane (0.2, 0.45, 1.2 µm) Glass fiber (3 µm) / Supor membrane (0.2, 1.2 µm) ■ 96-well filter plate, 1 mL Supor membrane (0.2, 0.45, 1.2 µm) Glass fiber (3 µm) / Supor membrane (0.2 µm) ■ 96-well filter plate, 2 mL Glass fiber (3 µm) / Supor membrane (1.2 µm) ■ 384-well filter plate, 100 µL Supor membrane (1.2 µm)
Price information
For inquiries regarding delivery dates and prices, please make your request through the inquiry form or the contact button.
Delivery Time
Applications/Examples of results
Pre-treatment of analytical test samples and biological samples - Filtration of water-soluble samples - Clarification of cells - Clarification of lysates - Filtration sterilization, removal of microplasma
Company information
Cytiva and Pall Life Sciences have merged their businesses and will officially launch under the "Cytiva" brand on May 1, 2023. Under our mission of "Advancing therapies, faster," we will integrate both organizations and focus even more on supporting the development and manufacturing of better therapies for patients as a stronger global provider of technologies and services. The new Cytiva will offer a broader and deeper expertise and a rich lineup of products and services to better support various customers involved in research and the manufacturing and development of biopharmaceuticals, enabling them to deliver therapies to patients more quickly, from discovery to delivery. With a rich history spanning several hundred years, Pall Life Sciences and Cytiva, as part of the Danaher Group, will continue to unite to provide better services to our customers.
